Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Prostate Cancer

In brief

This is a prospective study to determine if the use of curcumin randomized against placebo will reduce cancer progression in patients with prostate cancer undergoing active surveillance.

Key facts

Study ID
NCT03769766
Run by
University of Texas Southwestern Medical Center
People needed
291
Starts
2019-03-11
Expected to finish
2030-11-01
Last updated by the study team
2026-06-15

Who can join

Age: 40 and older, up to 89. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.